Kazuko Kaneda‐Nakashima

2.4k total citations
69 papers, 1.7k citations indexed

About

Kazuko Kaneda‐Nakashima is a scholar working on Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Kazuko Kaneda‐Nakashima has authored 69 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Radiology, Nuclear Medicine and Imaging, 16 papers in Pulmonary and Respiratory Medicine and 15 papers in Oncology. Recurrent topics in Kazuko Kaneda‐Nakashima's work include Radiopharmaceutical Chemistry and Applications (20 papers), Peptidase Inhibition and Analysis (10 papers) and Amino Acid Enzymes and Metabolism (9 papers). Kazuko Kaneda‐Nakashima is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (20 papers), Peptidase Inhibition and Analysis (10 papers) and Amino Acid Enzymes and Metabolism (9 papers). Kazuko Kaneda‐Nakashima collaborates with scholars based in Japan, Germany and United States. Kazuko Kaneda‐Nakashima's co-authors include Kazuhiro Ooe, Atsushi Toyoshima, Yoshifumi Shirakami, Tadashi Watabe, Atsushi Shinohara, Jun Hatazawa, Yuwei Liu, Taro Shirakawa, Eku Shimosegawa and Frederik L. Giesel and has published in prestigious journals such as PLoS ONE, Molecular and Cellular Biology and Journal of Virology.

In The Last Decade

Kazuko Kaneda‐Nakashima

66 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kazuko Kaneda‐Nakashima Japan	23	552	451	378	369	246	69	1.7k
Alan Alfieri United States	28	584 1.1×	595 1.3×	816 2.2×	278 0.8×	361 1.5×	66	2.6k
Olivier D. Christophe France	37	433 0.8×	349 0.8×	1.3k 3.4×	927 2.5×	372 1.5×	144	4.4k
Masayuki Tsuchiya Japan	23	341 0.6×	320 0.7×	869 2.3×	626 1.7×	101 0.4×	39	1.9k
Kun Peng China	26	196 0.4×	444 1.0×	967 2.6×	443 1.2×	403 1.6×	84	2.5k
Alessandra Romano Italy	30	721 1.3×	96 0.2×	890 2.4×	644 1.7×	107 0.4×	187	2.6k
Susan Wang United States	18	228 0.4×	276 0.6×	1.1k 2.9×	450 1.2×	377 1.5×	26	2.5k
Kwan‐Hwa Chi Taiwan	24	680 1.2×	111 0.2×	494 1.3×	366 1.0×	330 1.3×	63	1.8k
Pauline L. Martin United States	25	326 0.6×	359 0.8×	498 1.3×	667 1.8×	106 0.4×	43	1.6k
R.J. Scheper Netherlands	24	1.3k 2.4×	237 0.5×	816 2.2×	431 1.2×	306 1.2×	57	2.3k
David P. Houchens United States	21	692 1.3×	505 1.1×	485 1.3×	207 0.6×	274 1.1×	41	1.8k

Countries citing papers authored by Kazuko Kaneda‐Nakashima

Since Specialization

Citations

This map shows the geographic impact of Kazuko Kaneda‐Nakashima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kazuko Kaneda‐Nakashima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kazuko Kaneda‐Nakashima more than expected).

Fields of papers citing papers by Kazuko Kaneda‐Nakashima

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kazuko Kaneda‐Nakashima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kazuko Kaneda‐Nakashima. The network helps show where Kazuko Kaneda‐Nakashima may publish in the future.

Co-authorship network of co-authors of Kazuko Kaneda‐Nakashima

This figure shows the co-authorship network connecting the top 25 collaborators of Kazuko Kaneda‐Nakashima. A scholar is included among the top collaborators of Kazuko Kaneda‐Nakashima based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kazuko Kaneda‐Nakashima. Kazuko Kaneda‐Nakashima is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Imura, Yoshinori, et al.. (2025). LAT1-Targeted Alpha Therapy Using 211At-AAMT for Bone and Soft Tissue Sarcomas. International Journal of Molecular Sciences. 26(17). 8599–8599. 1 indexed citations

Watabe, Tadashi, Sadahiro Naka, Yoshifumi Shirakami, et al.. (2025). Development of PSMA-Targeted Alpha Therapy Using [211At]PSMA-5. Seminars in Nuclear Medicine. 55(6). 947–954. 1 indexed citations

Kaneda‐Nakashima, Kazuko, Yoshifumi Shirakami, K Hisada, et al.. (2024). Development of LAT1-Selective Nuclear Medicine Therapeutics Using Astatine-211. International Journal of Molecular Sciences. 25(22). 12386–12386. 2 indexed citations

Hisada, K, Kazuko Kaneda‐Nakashima, Yoshifumi Shirakami, et al.. (2024). Comparison Length of Linker in Compound for Nuclear Medicine Targeting Fibroblast Activation Protein as Molecular Target. International Journal of Molecular Sciences. 25(22). 12296–12296.

Abe, Kaori, Tadashi Watabe, Kazuko Kaneda‐Nakashima, et al.. (2024). Evaluation of Targeted Alpha Therapy Using [211At]FAPI1 in Triple-Negative Breast Cancer Xenograft Models. International Journal of Molecular Sciences. 25(21). 11567–11567. 2 indexed citations

Watabe, Tadashi, Kazuko Kaneda‐Nakashima, Yuichiro Kadonaga, et al.. (2024). Preclinical Evaluation of Biodistribution and Toxicity of [211At]PSMA-5 in Mice and Primates for the Targeted Alpha Therapy against Prostate Cancer. International Journal of Molecular Sciences. 25(11). 5667–5667. 9 indexed citations

Shi, Zitong, Kazuko Kaneda‐Nakashima, Ryuichi Ohgaki, et al.. (2023). Inhibition of cancer-type amino acid transporter LAT1 suppresses B16-F10 melanoma metastasis in mouse models. Scientific Reports. 13(1). 13943–13943. 12 indexed citations

Kadonaga, Yuichiro, Yoshifumi Shirakami, Tadashi Watabe, et al.. (2023). Evaluation of Astatine-211-Labeled Fibroblast Activation Protein Inhibitor (FAPI): Comparison of Different Linkers with Polyethylene Glycol and Piperazine. International Journal of Molecular Sciences. 24(10). 8701–8701. 19 indexed citations

Watabe, Tadashi, Kazuya Kabayama, Sadahiro Naka, et al.. (2023). Immuno-PET and Targeted α-Therapy Using Anti–Glypican-1 Antibody Labeled with⁸⁹Zr or²¹¹At: A Theranostic Approach for Pancreatic Ductal Adenocarcinoma. Journal of Nuclear Medicine. 64(12). 1949–1955. 13 indexed citations

10.

Kaneda‐Nakashima, Kazuko, Yoshifumi Shirakami, Tadashi Watabe, et al.. (2022). Effect to Therapy of Sodium-Iodine Symporter Expression by Alpha-Ray Therapeutic Agent via Sodium/Iodine Symporter. International Journal of Molecular Sciences. 23(24). 15509–15509. 2 indexed citations

11.

Liu, Yuwei, Tadashi Watabe, Kazuko Kaneda‐Nakashima, et al.. (2021). Fibroblast activation protein targeted therapy using [177Lu]FAPI-46 compared with [225Ac]FAPI-46 in a pancreatic cancer model. European Journal of Nuclear Medicine and Molecular Imaging. 49(3). 871–880. 134 indexed citations

12.

Kaneda‐Nakashima, Kazuko, Tomonaga Ichikawa, Tomohisa Sekimoto, et al.. (2021). Role of Mel1/Prdm16 in bone differentiation and morphology. Experimental Cell Research. 410(2). 112969–112969. 9 indexed citations

13.

Kaneda‐Nakashima, Kazuko, Zijian Zhang, Yoshiyuki Manabe, et al.. (2020). α‐Emitting cancer therapy using ²¹¹At‐AAMT targeting LAT1. Cancer Science. 112(3). 1132–1140. 35 indexed citations

14.

Watabe, Tadashi, Yuwei Liu, Kazuko Kaneda‐Nakashima, et al.. (2019). Theranostics Targeting Fibroblast Activation Protein in the Tumor Stroma: ⁶⁴Cu- and ²²⁵Ac-Labeled FAPI-04 in Pancreatic Cancer Xenograft Mouse Models. Journal of Nuclear Medicine. 61(4). 563–569. 228 indexed citations

15.

Yamakawa, Norio, et al.. (2012). The Increased Expression of Integrin α6 (ITGA6) Enhances Drug Resistance in EVI1high Leukemia. PLoS ONE. 7(1). e30706–e30706. 56 indexed citations

16.

Sakurai, Fuminori, Kazuko Kaneda‐Nakashima, Tomoko Yamaguchi, et al.. (2010). Adenovirus serotype 35 vector-induced innate immune responses in dendritic cells derived from wild-type and human CD46-transgenic mice: Comparison with a fiber-substituted Ad vector containing fiber proteins of Ad serotype 35. Journal of Controlled Release. 148(2). 212–218. 14 indexed citations

17.

Harada, Michishige, Kazuko Kaneda‐Nakashima, Tomomitsu Hirota, et al.. (2006). Functional Polymorphism in the Suppressor of Cytokine Signaling 1 Gene Associated with Adult Asthma. American Journal of Respiratory Cell and Molecular Biology. 36(4). 491–496. 84 indexed citations

18.

Shimizu, Makiko, Akira Matsuda, Ken Yanagisawa, et al.. (2005). Functional SNPs in the distal promoter of the ST2 gene are associated with atopic dermatitis. Human Molecular Genetics. 14(19). 2919–2927. 147 indexed citations

19.

Akahoshi, Mitsuteru, Mami Ishihara, Natascha Remus, et al.. (2004). Association between IFNA genotype and the risk of sarcoidosis. Human Genetics. 114(5). 503–509. 64 indexed citations

20.

Fukuda, Sanae, Hiroki Ishikawa, Yasuhiro Koga, et al.. (2004). Allergic symptoms and microflora in schoolchildren. Journal of Adolescent Health. 35(2). 156–158. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact